Premium
JB Chemicals & Pharmaceuticals Ltd, in which global private equity giant KKR is set to acquire a controlling stake, has agreed to purchase the finished pharmaceutical formulations business of a domestic company. The Mumbai-based company will acquire the business from Lekar Pharma Ltd for Rs 8.5 crore ($1.13 million). Lekar Pharma ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
